Decreased blood CD4+PD-1+and CD8+PD-1+T cells in psoriatic patients with and without arthritis

被引:18
|
作者
Bartosinska, Joanna [1 ]
Zakrzewska, Ewelina [2 ]
Purkot, Joanna [2 ]
Michalak-Stoma, Anna [1 ]
Kowal, Malgorzata [1 ]
Krasowska, Dorota [1 ]
Chodorowska, Grazyna [1 ]
Giannopoulos, Krzysztof [2 ]
机构
[1] Med Univ Lublin, Dept Dermatol Venereol & Paediat Dermatol, 13 Radziwillowska St, PL-20080 Lublin, Poland
[2] Med Univ Lublin, Expt Hematooncol Dept, Lublin, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2018年 / 35卷 / 04期
关键词
psoriasis; psoriatic arthritis; programmed death 1; COLLAGEN-INDUCED ARTHRITIS; PDCD1; GENE; T-CELLS; ASSOCIATION; PD-1; TH17;
D O I
10.5114/ada.2018.75609
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Psoriasis with and without arthritis have common immunological mechanisms which among others involve the interactions between cytokines produced by T cells, including Th1, Th17 and Th22. Although quite a lot is known about psoriasis pathogenesis, the cause of chronic immune activation and response in the disease remains unclear. One of the negative regulators of the immune system is programmed death 1 (PD-1). Aim: To assess the expression level of PD-1 in the peripheral T cells of psoriatic patients with and without arthritis. Material and methods: The study included 23 psoriatic patients with arthritis, 52 psoriatic patients without arthritis and 52 healthy controls. The percentages of CD3+, CD4+, CD8+, CD4+PD-1+ and CD8+PD-1+ T cells were analyzed using flow cytometry. Results: The percentages of CD4+PD-1+ as well as CD8+PD-1+ T cells in the psoriatic patients both with and without arthritis were significantly lower than in the control group. The percentages of CD4+PD-1+ as well as CD8+PD-1+ T cells were not significantly different between the psoriatic patients with and without arthritis. A significant positive correlation between PD-1 expression on the CD4+ and CD8+ T cells was found in the psoriatic patients without arthritis. Conclusions: Impairment of the negative co-stimulation from PD-1 may be another common characteristic of psoriasis both with and without arthritis.
引用
收藏
页码:344 / 350
页数:7
相关论文
共 50 条
  • [31] cAMP Response Element Modulator (CREM)α Promotes PD-1-effector CD4+T Cells in Psoriasis and Psoriatic Arthritis
    Hofmann, Sigrun
    Kapplusch, Franz
    Abraham, Susanne
    Northey, Sarah
    Russ, Susanne
    Schulze, Felix
    Surace, Anna
    Hedrich, Christian
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [32] Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
    Zhu, Qian
    Qiao, Guoliang
    Huang, Lefu
    Xu, Chang
    Guo, Deliang
    Wang, Shuo
    Zhao, Jing
    Song, Yuguang
    Liu, Bing
    Chen, Zheng
    Yang, Zhiyong
    Yuan, Yufeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
    Duchemann, Boris
    Naigeon, Marie
    Auclin, Edouard
    Ferrara, Roberto
    Cassard, Lydie
    Jouniaux, Jean-Mehdi
    Boselli, Lisa
    Grivel, Jonathan
    Desnoyer, Aude
    Danlos, Francois-Xavier
    Mezquita, Laura
    Caramella, Caroline
    Marabelle, Aurelien
    Besse, Benjamin
    Chaput, Nathalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [34] Prognostic Values of CD38+CD101+PD1+CD8+ T Cells in Pancreatic Cancer
    Zhang, Mengjie
    Yang, Jiali
    Zhou, Jian
    Gao, Weiwu
    Zhang, Yi
    Lin, Yuxin
    Wang, Huaizhi
    Ruan, Zhihua
    Ni, Bing
    IMMUNOLOGICAL INVESTIGATIONS, 2019, 48 (05) : 466 - 479
  • [35] Prognostic values of CD38+CD101+PD1+CD8+ T cells in pancreatic cancer
    Ni, B.
    Zhang, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 401 - 401
  • [36] Resistance to immunotherapy is associated with high parenchymal PD1+CD8+/CD8+T cells (PD1tR) driven by tumour CD155
    de Oliveira, A. Lepletier
    Madore, J.
    O'donnell, S.
    Johnston, R. L.
    Eastgate, M.
    Mallardo, D.
    Ascierto, P. A.
    Massi, D.
    Merelli, B.
    Mandala, M.
    Wilmott, J. S.
    Bald, T.
    Stagg, J.
    Routy, B.
    Long, G. V.
    Scolyer, R. A.
    Waddell, N.
    Dougall, W. C.
    Teng, M. W. L.
    Smyth, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
    Yang, Xiaobao
    Wang, Guanzheng
    Song, Yue
    Zhuang, Tongtao
    Li, Yifei
    Xie, Yujie
    Fei, Xuefeng
    Zhao, Yanan
    Xu, Dakang
    Hu, Yiqun
    CANCERS, 2023, 15 (05)
  • [38] PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes
    Li, Xia
    Zhong, Ting
    Tang, Rong
    Wu, Chao
    Xie, Yuting
    Liu, Fang
    Zhou, Zhiguang
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (06): : 1947 - 1956
  • [39] Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma
    Nowicki, Theodore S.
    Akiyama, Ryan
    Huang, Rong Rong
    Shintaku, I. Peter
    Wang, Xiaoyan
    Tumeh, Paul C.
    Singh, Arun
    Chmielowski, Bartosz
    Denny, Christopher
    Federman, Noah
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (02) : 118 - 126
  • [40] PD-1-functionality and CD28 molecule expression in CD8+T-cells of cancer patients
    Palermo, Belinda
    Franzese, Ornella
    Panetta, Mariangela
    Ferraresi, Virginia
    Alessandrini, Gabriele
    Facciolo, Franco
    Ciliberto, Gennaro
    Nistico, Paola
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)